---
figid: PMC8836921__ijms-23-01809-g001
figtitle: 'IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and
  Treatment'
organisms:
- Escherichia coli
- Staphylococcus aureus
- Homo sapiens
- Mus musculus
- Bos taurus
pmcid: PMC8836921
filename: ijms-23-01809-g001.jpg
figlink: /pmc/articles/PMC8836921/figure/ijms-23-01809-f001/
number: F1
caption: IL-6 cytokine pathway activation in breast cancer cells. IL-6 is secreted
  by tumor and stroma cells, such as cancer associated adipocytes (CAAs), cancer associated
  fibroblasts (CAFs), lymphatic endothelial cells (LECs), and myeloid derived stem
  cells (MDSCs). IL-6 binds to either transmembrane (mIL-6R) or soluble (sIL-6R) IL-6
  receptor and to gp130 inducing ‘classic signaling’ through mIL-6R or ‘trans-signaling’
  through sIL-6R (A). LIF binds to transmembrane LIF receptor (mLIFR) and gp130 inducing
  downstream signaling. LIF binding to soluble LIF receptors (sLIFR) blocks interaction
  with gp130 inhibiting LIF pathway activation (B). At the surface of target cells,
  secreted IL-6 cytokine family members bind to their specific receptors and gp130
  to activate intracellular signaling cascades (C).
papertitle: 'IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention
  and Treatment.'
reftext: Carla M. Felcher, et al. Int J Mol Sci. 2022 Feb;23(3):1809.
year: '2022'
doi: 10.3390/ijms23031809
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: breast cancer | IL-6 | LIF | OSM | IL-11 | mastitis | tumor microenvironment
automl_pathway: 0.9417223
figid_alias: PMC8836921__F1
figtype: Figure
organisms_ner:
- Bos taurus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC8836921__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8836921__ijms-23-01809-g001.html
  '@type': Dataset
  description: IL-6 cytokine pathway activation in breast cancer cells. IL-6 is secreted
    by tumor and stroma cells, such as cancer associated adipocytes (CAAs), cancer
    associated fibroblasts (CAFs), lymphatic endothelial cells (LECs), and myeloid
    derived stem cells (MDSCs). IL-6 binds to either transmembrane (mIL-6R) or soluble
    (sIL-6R) IL-6 receptor and to gp130 inducing ‘classic signaling’ through mIL-6R
    or ‘trans-signaling’ through sIL-6R (A). LIF binds to transmembrane LIF receptor
    (mLIFR) and gp130 inducing downstream signaling. LIF binding to soluble LIF receptors
    (sLIFR) blocks interaction with gp130 inhibiting LIF pathway activation (B). At
    the surface of target cells, secreted IL-6 cytokine family members bind to their
    specific receptors and gp130 to activate intracellular signaling cascades (C).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LIF
  - IL6
  - IL6R
  - LIFR
  - OSM
  - PIK3CB
  - AKT1
  - OSMR
  - IL11
  - TBX1
  - IL6ST
  - NM
  - LRPPRC
  - CCM2
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - AKT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - Lif
  - Lifr
  - Il6
  - Il6ra
  - Il11ra1
  - Il6st
  - Lrpprc
  - Osm
  - Pik3r1
  - Akt1
  - Osmr
  - Mdk
  - Ephb2
  - Mapk1
  - Il11
---
